MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Medical Devices & Technology (Technology)
*Driving Forces: Telemedicine,Telehealth, Mobile Health, mHealth, Virtual, Digital Health, DTx (Digital Therapeutics)
*Driving Forces: Telemedicine,Telehealth, mHealth & Home Health (Sectors)
*Driving Forces: Primary Care, Chronic Disease, Wellness, Weight Loss, Obesity, Coordinated Care
2026: More patients are ordering lab tests online, frustrating some doctors
GRAIL, Inc. (NASDAQ:GRAL)
Organization & Developments: Grail
Parents
GRAIL, Inc. (NASDAQ:GRAL)
Children
*Grail's Galleri test
2016: A Single Blood Test For All Cancers? Illumina, Bill Gates And Jeff Bezos Launch Startup To Make It Happen_forbes
2016: GRAIL - Illumina Jumps into Cancer Screening with $100 Million Spin-off Grail
2017: The funding will support the development and validation of blood tests, including the Circulating Cell-free Genome Atlas study
2019: ASCO: In early study results, Grail's blood test identifies 12 cancers before they spread
2019: ESMO: Grail's multi-cancer blood test expands data in over 20 disease types
2019: Grail nets FDA breakthrough designation, turns eye toward DNA methylation for early cancer detection
2019: Grail Stays at Forefront of Liquid Biopsy Conversation with New Results
2020: Grail files for $100M IPO ahead of 2021 launch of multi-cancer liquid biopsy
2020: Illumina to Acquire GRAIL to Launch New Era of Cancer Detection_businesswire
2024: Grail to shed 350 workers in restructuring
2025: Cancer-Detecting Blood Tests Are on the Rise. Do They Work?
2025: GRAIL: Buy Τhe Test That Could Redefine Cancer Screening (NASDAQ:GRAL) | Seeking Alpha
2025: GRAIL: Cash Burn And Commercialization Timeline Are Problematic
2025: GRAIL: Intriguing Cancer Testing Product Needs More Time And FDA Approval
2026: A Blood Test That Screens for 50+ Cancers Just Moved Closer to Real-World Use. Here's What It Means for Grail Investors.
2026: Blood tests could transform cancer screening soon : NPR
2026: Grail’s Cancer Detection Test Fails in Major Study
2026: Multicancer blood test detects 17 cancer types in large prospective study
Jumps
*Key People: Grail
Finance & Acquisitions: Grail